Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Scientific Mass Spec User Meetings

Published: Tuesday, October 15, 2013
Last Updated: Tuesday, October 15, 2013
Bookmark and Share
Guest presenters from Harvard Medical School, Stanford, Michigan State University, Pfizer and Bristol Meyers Squibb and other organizations will describe how they apply the latest high resolution accurate mass spectrometry technology to a variety of challenging life science experiments.

Oct. 22, 2013, Somerset, NJ.

• Wilhelm Haas, Massachusetts General Hospital: Transforming Protein Quantitation with Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Josh Coon, University of Wisconsin: NeuCode SILAC and Parallel Reaction Monitoring using the Orbitrap Fusion Tribrid MS
• Gavin Reid, Michigan State University: Mass Spec Strategies for Comprehensive Lipidome Analysis to Identify Lipid Biomarkers of Disease
• Jessy YY Fan, Pfizer: Quantification of Therpeutic Protein Targets using Immunoaffinity and High Resolution Mass Spectrometry
• David Pirman, Pfizer: Monitoring the Metabolic Fate of Biological Substrates by High Resolution Mass Spectrometry

October 22, 2013, Foster City, CA

• Shenheng Guan, University of California, San Francisco: Orbitrap-based Native Mass Spectrometry for Characterization of Large Intact Protein Complexes
• Livia Eberlin, Stanford University: Desorption of Electrospray Ionization Mass Spectrometry Imaging in Biomedical Research
• Christopher Adams, Stanford University: Current State of Structural Proteomics
• Dan McKemie, University of California, Davis: Analysis of Morphine and Morphine Metabolites

October 24,Cambridge, MA.

• Steve Gygi, Harvard Medical School: Transforming Protein Quantitation with Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Anna Merrill, University of Wisconsin: NeuCode SILAC and Parallel Reaction Monitoring using the Orbitrap Fusion Tribrid MS
• Jack Henion Quintiles: High Resolution MS for the Quantitative Determination of Guanfacine in Dried Plasma Spots Derived from Molecular Filtration of Whole Blood

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos